Trinity Biotech plc
TRIBNASDAQHealthcare● Active
$0.68
+$0.01(+1.87%)
Market Cap$7063227
P/E Ratio—
52W High$3.44
52W Low$0.5
Trinity Biotech plc (TRIB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TRIB · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $43.92M | $61.55M | $56.83M | $62.52M | $81.15M |
| Cost of Revenue | $28.37M | $40.11M | $37.38M | $52.73M | $54.89M |
| Gross Profit | $15.55M | $21.44M | $19.45M | $22.05M | $33.45M |
| Gross Margin %(computed) | 35.40% | 34.83% | 34.22% | 35.26% | 41.23% |
| Operating Expenses | |||||
| R&D Expenses | $3.64M | $4.54M | $4.38M | $4.14M | $4.50M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $24.68M |
| Total Operating Expenses | $26.51M | $42.61M | $46.49M | $32.96M | $29.52M |
| Operating Income | ($10.96M) | ($21.16M) | ($27.05M) | ($15.27M) | $3.94M |
| Operating Margin %(computed) | -24.94% | -34.38% | -47.59% | -24.42% | 4.85% |
| Interest Income | $0.00M | $0.00M | $1.17M | $0.30M | $1.22M |
| Interest Expense | $21.45M | $9.56M | $10.15M | $24.73M | $7.10M |
| Income Before Tax | ($37.29M) | ($30.73M) | ($36.93M) | ($43.78M) | ($1.92M) |
| Income Tax Expense | $0.20M | $0.49M | ($0.06M) | ($0.19M) | ($0.07M) |
| Net Income | ($37.49M) | ($31.79M) | ($24.02M) | ($41.00M) | $0.88M |
| Net Margin %(computed) | -85.36% | -51.64% | -42.26% | -65.58% | 1.08% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.00 | $-1.77 | $-3.20 | $-6.00 | $0.21 |
| Wtd Avg Shares | 18.58M | 17.96M | 7.65M | 6.75M | 4.18M |
| EBITDA | ($8.26M) | ($16.91M) | ($24.10M) | ($16.71M) | $10.59M |
| EBITDA Margin %(computed) | -18.81% | -27.46% | -42.40% | -26.73% | 13.05% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Trinity Biotech plc data
About Trinity Biotech plc (TRIB) Income Statement
Trinity Biotech plc (TRIB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, TRIB reported revenue of $0.04B, gross profit of $0.02B (gross margin 35.40%), and net income of ($0.04B) — a net profit margin of -85.36%.
Frequently asked questions
TRIB · 4 questionsTrinity Biotech plc (TRIB) reported revenue of $0.04B for 2025, down 28.6% year-over-year.
TRIB revenueTRIB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09